BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 7718050)

  • 21. Enhanced angiotensin II-induced activation of Na+, K+-ATPase in the proximal tubules of obese Zucker rats.
    Shah S; Hussain T
    Clin Exp Hypertens; 2006 Jan; 28(1):29-40. PubMed ID: 16443562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin II infusion decreases plasma adiponectin level via its type 1 receptor in rats: an implication for hypertension-related insulin resistance.
    Ran J; Hirano T; Fukui T; Saito K; Kageyama H; Okada K; Adachi M
    Metabolism; 2006 Apr; 55(4):478-88. PubMed ID: 16546478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential modulation of baroreflex control of heart rate by neuron- vs. glia-derived angiotensin II.
    Sakai K; Chapleau MW; Morimoto S; Cassell MD; Sigmund CD
    Physiol Genomics; 2004 Dec; 20(1):66-72. PubMed ID: 15467015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The possible role of sense and antisense peptide interactions in the generation and maintenance of the tertiary structure of a protein.
    Okada H
    Anticancer Res; 1998; 18(5D):3927-30. PubMed ID: 9854505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Photoaffinity labeling of subtype 2 angiotensin receptor of human myometrium.
    Servant G; Boulay G; Bossé R; Escher E; Guillemette G
    Mol Pharmacol; 1993 May; 43(5):677-83. PubMed ID: 8502225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A simple three-step method for design and affinity testing of new antisense peptides: an example of erythropoietin.
    Štambuk N; Manojlović Z; Turčić P; Martinić R; Konjevoda P; Weitner T; Wardega P; Gabričević M
    Int J Mol Sci; 2014 May; 15(6):9209-23. PubMed ID: 24865486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Photochemical conjugation of peptides to carrier proteins using 1,2,3-thiadiazole-4-carboxylic acid. Immunoreactivity of free C-terminal epitope with specific antibodies.
    Hansen PR; Flyge H; Holm A; Lauritzen E; Larsen BD
    Int J Pept Protein Res; 1996 Jun; 47(6):419-26. PubMed ID: 8836769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo applications of antisense oligonucleotides for peptide research.
    Phillips MI; Gyurko R
    Regul Pept; 1995 Oct; 59(2):131-41. PubMed ID: 8584748
    [No Abstract]   [Full Text] [Related]  

  • 29. Molecular Recognition Theory of the complementary (antisense) peptide interactions.
    Stambuk N; Konjevoda P; Boban-Blagaić A; Pokrić B
    Theory Biosci; 2005 Apr; 123(4):265-75. PubMed ID: 18202868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The statistical significance of selected sense-antisense peptide interactions.
    Illingworth CJ; Chintipalli SV; Serapian SA; Miller AD; Veverka V; Carr MD; Reynolds CA
    J Comput Chem; 2012 Jun; 33(16):1440-7. PubMed ID: 22488506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactions and uses of antisense peptides in affinity technology.
    Chaiken I
    J Chromatogr; 1992 Apr; 597(1-2):29-36. PubMed ID: 1517330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Problems of activated peptides in pathogenetic analysis].
    Moriya H
    Saishin Igaku; 1967 May; 22(5):865-7. PubMed ID: 4294959
    [No Abstract]   [Full Text] [Related]  

  • 33. More about complementary hydropathy.
    Brentani RR
    Trends Biotechnol; 1990 Oct; 8(10):281-2. PubMed ID: 1366727
    [No Abstract]   [Full Text] [Related]  

  • 34. A micro end-group method for peptides.
    INGRAM VM
    Nature; 1950 Dec; 166(4233):1038. PubMed ID: 14796687
    [No Abstract]   [Full Text] [Related]  

  • 35. Antisense Peptide Technology for Diagnostic Tests and Bioengineering Research.
    Štambuk N; Konjevoda P; Pavan J
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antisense-designed peptides: a comparative study focusing on possible complements to angiotensin II.
    Holsworth DD; Kiely JS; Root-Bernstein RS; Overhiser RW
    Pept Res; 1994; 7(4):185-93. PubMed ID: 7718050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purification of an angiotensin II binding protein by using antibodies to a peptide encoded by angiotensin II complementary RNA.
    Elton TS; Dion LD; Bost KL; Oparil S; Blalock JE
    Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2518-22. PubMed ID: 2451826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NMR study of the possible interaction in solution of angiotensin II with a peptide encoded by angiotensin II complementary RNA.
    Eaton HL; Austin RE; Fesik SW; Martin SF
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):9767-9. PubMed ID: 2481315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of electrospray ionization mass spectrometry to probe antisense peptide interactions.
    Loo JA; Holsworth DD; Root-Bernstein RS
    Biol Mass Spectrom; 1994 Jan; 23(1):6-12. PubMed ID: 8155747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peptide self-aggregation and peptide complementarity as bases for the evolution of peptide receptors: a review.
    Root-Bernstein RS
    J Mol Recognit; 2005; 18(1):40-9. PubMed ID: 15384177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.